Zobrazeno 1 - 10
of 25
pro vyhledávání: '"Neal Klein"'
Autor:
Neal Klein, William Frishman, Nusen Beer, Aaron A. Cohen, Ivan Gallegos, Edmund H. Sonnenblick
Publikováno v:
Chest. 79:571-574
The effects of sublingual nifedipine, a calcium antagonist vasodilator, were assessed in 43 patients with moderate to severe hypertension in an emergency room setting. Following a no-response placebo treatment period, the patients with supine diastol
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6d50c0fd423837f0d4342fee9acb923c
https://doi.org/10.1378/chest.79.5.571
https://doi.org/10.1378/chest.79.5.571
Autor:
Joel A. Strom, William H. Frishman, Robert Tawil, Simcha Pollack, Steven Roth, Neal Klein, Thierry H. LeJemtel, Edmund H. Sonnenblick, Philip Klein, Bowen Wong, Roger K. Strair
Publikováno v:
The American Journal of Cardiology. 50:1164-1172
The relative efficacies of oral verapamil, a calcium-entry blocking drug, and propranolol, a beta-adrenergic blocking drug, were compared in 12 patients who had both stable angina pectoris and mild to moderate systemic hypertension, using a placebo-c
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::ac1f7030a7887b2620d57f886b194f17
https://doi.org/10.1016/0002-9149(82)90438-6
https://doi.org/10.1016/0002-9149(82)90438-6
Autor:
Thierry H. LeJemtel, Stanley Halprin, Marcia P. Poland, Marc Kirschner, Neal Klein, William H. Frishman, Michael Kram, Edmund H. Sonnenblick, Joel A. Strom
Publikováno v:
The American Journal of Cardiology. 48:917-928
The effects of oral labetalol, an alpha-beta adrenoceptor blocker, were evaluated in 10 patients with angina pectoris and hypertension. After 3 weeks of placebo, increasing doses of labetalol (300 to 1,200 mg/day) were given over 4 weeks followed by
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::648448cdfb6bff7f111fd14b2858d4be
https://doi.org/10.1016/0002-9149(81)90359-3
https://doi.org/10.1016/0002-9149(81)90359-3
Autor:
Neal Klein, George Phillippides, Bruce Kimmel, William H. Frishman, Jeffrey Goldberger, Shlomo Charlap
Publikováno v:
The American Journal of Cardiology. 57:D22-D29
Calcium-channel blockers have been successfully used in the treatment of angina of effort and systemic hypertension. Many patients present with concomitant angina pectoris and hypertension. Controlled clinical trials demonstrate that the calcium-chan
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::fb2bc552bd04d94c910b22752c0a5300
https://doi.org/10.1016/0002-9149(86)90801-5
https://doi.org/10.1016/0002-9149(86)90801-5
Publikováno v:
The American Journal of Medicine. 72:113-118
Six patients with severe congestive heart failure refractory to conventional therapy, including vasodilators, were treated with oral amrinone for a mean duration of 41 weeks (range 20 to 72 weeks). At initiation of therapy, the cardiac index increase
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::0a11849487f8450eda11bc35c3ee15a7
https://doi.org/10.1016/0002-9343(82)90597-6
https://doi.org/10.1016/0002-9343(82)90597-6
Autor:
Simcha Pollack, Thierry H. LeJemtel, William H. Frishman, Edmund H. Sonnenblick, Steven Roth, Louis Iorio, Harry Shamoon, Joel Strom, Philip Klein, Howard Willens, Martin N. Cohen, Neal Klein
Publikováno v:
The American journal of cardiology. 50(5)
The potential hazards of abrupt withdrawal of propranolol have been described in patients with angina pectoris; however, the effects of abrupt withdrawal from long-term therapy with verapamil have not previously been investigated. The comparative eff
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c35c087a2615d99ac9320b0cd00a58db
https://pubmed.ncbi.nlm.nih.gov/6814227
https://pubmed.ncbi.nlm.nih.gov/6814227
Autor:
Bruce Kimmel, Joel A. Strom, Neal Klein, Simcha Pollack, Joel Berezow, William H. Frishman, Howard Willens, Shlomo Charlap, Sharon Molinas, John P. Wexler
Publikováno v:
Angiology. 36(4)
The short-term (1 month) and long-term (6 months) safety of combination lidoflazine-propranolol therapy was investigated in an open trial of 15 patients with stable angina of effort. The possible advantages of adding lidoflazine (ti trated to 360 mg
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9e2bbb22419f587a1baf3866477d3c7e
https://pubmed.ncbi.nlm.nih.gov/4025935
https://pubmed.ncbi.nlm.nih.gov/4025935
Autor:
Edmund H. Sonnenblick, Neal Klein, William H. Frishman, Steve J. Siskind, Thierry H. LeJemtel
Publikováno v:
The American journal of cardiology. 48(1)
Amrinone, a new inotropic agent, has been shown to be beneficial in patients with congestive heart failure. However, its hemodynamic effects have not been compared with those those of currently useful catecholamines. In this study, the effects of int
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::366c4d4f5ac39cc10883308f33e5b222
https://pubmed.ncbi.nlm.nih.gov/7246440
https://pubmed.ncbi.nlm.nih.gov/7246440
Autor:
John P. Wexler, Anthony A. Losardo, William H. Frishman, Joel A. Strom, Nusen Beer, Neal Klein, Edmund H. Sonnenblick
Publikováno v:
Angiology. 33(12)
The effects of sublingual nifedipine, a calcium channel beta-blocking drug, were assessed in eleven patients with coronary artery disease and depressed left ventricular function. All patients had a previous documented myocardial infarction. Specifica
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1fff40c3d9f0d2d5388a901d27586afd
https://pubmed.ncbi.nlm.nih.gov/7181173
https://pubmed.ncbi.nlm.nih.gov/7181173
Publikováno v:
Archives of Internal Medicine. 141:843-844
During the last decade, a new class of calcium-inhibiting drugs has been applied in the treatment of symptomatic coronary artery disease. These compounds seemingly inhibit the inward passage of calcium across myocardial and vascular smooth-muscle cel
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::911587aedc4dc2770de6c2d935d2c518
https://doi.org/10.1001/archinte.141.7.843
https://doi.org/10.1001/archinte.141.7.843